Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
300204.SZ Stock Price Chart
Explore Staidson (Beijing) BioPharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300204.SZ price movements and trends.
300204.SZ Company Profile
Discover essential business fundamentals and corporate details for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Apr 2011
Employees
555.00
Website
https://www.staidson.comCEO
Wang Chao
Description
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
300204.SZ Financial Timeline
Browse a chronological timeline of Staidson (Beijing) BioPharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 16 Apr 2025
EPS came in at -¥0.28 , while revenue for the quarter reached ¥63.83M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.00 , while revenue for the quarter reached ¥63.21M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥78.60M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.00 , while revenue for the quarter reached ¥86.55M .
Earnings released on 16 Apr 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥93.72M .
Earnings released on 11 Jan 2024
EPS came in at -¥0.07 , while revenue for the quarter reached ¥105.09M .
Earnings released on 31 Dec 2023
EPS came in at -¥0.45 , while revenue for the quarter reached ¥89.43M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.22 , while revenue for the quarter reached ¥104.35M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.10 , while revenue for the quarter reached ¥65.02M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.08 , while revenue for the quarter reached ¥166.07M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.15 , while revenue for the quarter reached ¥135.77M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.12 , while revenue for the quarter reached ¥123.81M .
Earnings released on 21 Apr 2022
EPS came in at -¥0.02 , while revenue for the quarter reached ¥157.98M .
Earnings released on 31 Mar 2022
EPS came in at -¥0.05 , while revenue for the quarter reached ¥123.34M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.14 , while revenue for the quarter reached ¥153.68M .
Earnings released on 30 Jun 2021
EPS came in at -¥0.08 , while revenue for the quarter reached ¥157.18M .
Earnings released on 31 Mar 2021
EPS came in at -¥0.04 , while revenue for the quarter reached ¥115.46M .
Earnings released on 31 Dec 2020
EPS came in at -¥0.07 , while revenue for the quarter reached ¥129.01M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.05 , while revenue for the quarter reached ¥130.22M .
300204.SZ Stock Performance
Access detailed 300204.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.